1. How to read this article
This is a portal version of the supplied “Top Companies Radiopharmaceuticals” image. The image contains 23 companies and short descriptions of their areas: PET/SPECT, radioisotopes, radioligand therapy, targeted alpha therapy, nuclear pharmacy, radiopharmaceutical logistics and broader oncology/imaging portfolios.
The structure follows the earlier Lumex/LabEx top-manufacturers article: company → area → possible QC scenario → FUZKK utilities that can turn laboratory or manufacturing output into a reproducible QA/QC decision.
Related FUZKK packages
RPH combines PetRad, PetRad2 and PetRad3: PET/SPECT, generators, therapeutic radionuclides, targeted alpha therapy, radiochemical purity, breakthrough, sterility, endotoxins, decay calculations and preliminary dosimetry.
2. Where FUZKK helps in a radiopharmaceutical workflow
3. Companies from the image
4. Company cards and QC scenarios
Each line from the image is converted into a portal card. Utilities are shown as practical coverage scenarios; this does not claim an existing integration with the company.
1 GE HealthCareUnited States marker · PET/SPECT diagnostic imaging, molecular imaging, contrast media
What was read from the image
Diagnostic imaging, PET tracers, radiopharmaceuticals, molecular imaging systems and contrast media.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
2 Eckert & ZieglerGermany marker · radioisotopes, manufacturing components, therapy isotopes
What was read from the image
Radioisotopes, radiopharmaceutical manufacturing, nuclear medicine components and cancer-therapy isotopes.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
3 PRECIRIXUnited States marker in image · targeted therapy, precision oncology, radioligands
What was read from the image
Targeted radiopharmaceutical cancer therapies and precision-oncology products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
4 CuriumFrance marker · PET/SPECT agents, therapeutics, nuclear medicine
What was read from the image
PET and SPECT imaging agents, therapeutics and nuclear-medicine products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
5 Jubilant PharmovaIndia marker · radiopharmaceuticals, CMO/CDMO, APIs
What was read from the image
Radiopharmaceuticals, allergy-therapy products, contract manufacturing and APIs.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
6 SOFIEBelgium marker · PET tracers, manufacturing, molecular imaging
What was read from the image
PET imaging tracers, radiopharmaceutical manufacturing and molecular-imaging solutions.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
7 Isotopia Molecular ImagingUnited States marker in image · therapeutic isotopes, PET tracers, nuclear medicine
What was read from the image
Therapeutic isotopes, PET tracers and nuclear-medicine solutions.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
8 BraccoItaly marker · contrast agents, diagnostic imaging, MRI/ultrasound
What was read from the image
Contrast agents, diagnostic-imaging products, MRI and ultrasound solutions.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
9 NorthStar Medical RadioisotopesUnited States marker · Mo-99, medical radioisotopes, therapeutic isotopes
What was read from the image
Medical radioisotopes, Mo-99 production and therapeutic isotopes.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
10 NovartisSwitzerland marker · radioligand therapy, oncology, therapeutics
What was read from the image
Oncology drugs, radioligand therapy, innovative medicine and gene therapy.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
11 EczacıbaşıTurkey marker · healthcare products, pharmaceuticals, distribution context
What was read from the image
Pharmaceutical and healthcare products, consumer healthcare and building products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
12 Fusion PharmaceuticalsCanada marker · targeted alpha therapy, oncology radiopharmaceuticals, TAT
What was read from the image
Targeted alpha therapies and oncology radiopharmaceuticals.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
13 Nihon Medi-PhysicsJapan marker · PET tracers, diagnostic radiopharmaceuticals, nuclear medicine agents
What was read from the image
PET tracers, diagnostic radiopharmaceuticals and nuclear-medicine agents.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
14 ROSATOMRussia marker · radioisotopes, nuclear medicine technologies, radiation products
What was read from the image
Nuclear energy, radioisotopes, nuclear-medicine technologies and radiation products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
15 NTP / NecsaSouth Africa marker · radioisotope production, healthcare isotopes, radiation technology
What was read from the image
Radioisotope production, nuclear fuel, radiation technologies and healthcare isotopes.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
16 Cardinal HealthUnited States marker · nuclear pharmacy, distribution, radiopharmaceutical logistics
What was read from the image
Nuclear-pharmacy services, medical-products distribution and radiopharmaceutical logistics.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
17 Actinium PharmaceuticalsUnited States marker · targeted radiotherapy, alpha emitters, oncology
What was read from the image
Targeted radiotherapies, oncology biologics and alpha-emitting therapies.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
18 Telix PharmaceuticalsAustralia marker · diagnostics, therapeutics, oncology imaging
What was read from the image
Diagnostic and therapeutic radiopharmaceuticals and oncology-imaging agents.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
19 LantheusUnited States marker · diagnostic imaging, PET products, ultrasound contrast
What was read from the image
Diagnostic imaging agents, PET products and ultrasound contrast agents.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
20 Clarity PharmaceuticalsUnited States marker in image · precision oncology, therapy, imaging
What was read from the image
Radiopharmaceutical therapies and precision-oncology imaging products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
21 BayerGermany marker · oncology therapies, radiology products, pharmaceuticals
What was read from the image
Pharmaceuticals, oncology therapies, radiology products and consumer healthcare.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
22 ITM Isotope Technologies MunichGermany marker · medical isotopes, targeted radionuclide therapy, development
What was read from the image
Medical isotopes, targeted radionuclide therapies and radiopharmaceutical development.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
23 LillyUnited States marker · oncology portfolio, broader pharmaceutical context, clinical adoption context
What was read from the image
Diabetes medicines, oncology drugs, immunology therapies and neuroscience products.
This is not supplier qualification or a GMP audit. The line is used as input for a portal article and a preliminary market map.
FUZKK QC angle
Connect the company/product context with batch checks: radionuclide identity and purity, radiochemical purity, activity at release time, decay correction, usage window and structured JSON for QA review.
Applicable utilities / scenarios
5. Practical positioning
For Head of QC
Show which checks can be standardised around PET/SPECT and therapeutic radiopharmaceuticals.
For QA / CSV
Describe the validation perimeter: URS/FS, IQ/OQ, controlled CSV input and reproducible JSON output.
For integration
Use the article as a discussion map: from equipment and radioisotopes to LIMS/ELN/MES and batch release.